RXFP3 and obesity due to melanocortin 4 receptor deficiency: Determining whether RXFP3 antagonists are protective against the obesity and metabolic syndromes induced by high fat diets in rodents is also a logical and important goal (Panchal and Brown, 2011; Ganella et al., 2012).